Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD

OBJECTIVE: To investigate whether aquaporin-4–immunoglobulin G (AQP4-IgG) titers and measures of complement-mediated cell killing are clinically useful to predict the occurrence of relapse, relapse severity, and/or disability in neuromyelitis optica spectrum disorder (NMOSD). METHODS: We studied 336...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Jitprapaikulsan, Jiraporn, Fryer, James P., Majed, Masoud, Smith, Carin Y., Jenkins, Sarah M., Cabre, Philippe, Hinson, Shannon R., Weinshenker, Brian G., Mandrekar, Jay, Chen, John J., Lucchinetti, Claudia F., Jiao, Yujuan, Segan, Jessica, Schmeling, John E., Mills, John, Flanagan, Eoin P., McKeon, Andrew, Pittock, Sean J.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7286655/
https://ncbi.nlm.nih.gov/pubmed/35413004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000727
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars